Literature DB >> 15500446

Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.

Meaghan Stolk1, Elizabeth Cooper, Greg Vilk, David W Litchfield, James R Hammond.   

Abstract

Two subtypes of equilibrative transporters, es (equilibrative inhibitor-sensitive) and ei (equilibrative inhibitor-insensitive), are responsible for the majority of nucleoside flux across mammalian cell membranes. Sequence analyses of the representative genes, ENT1 {equilibrative nucleoside transporter 1; also known as SLC29A1 [solute carrier family 29 (nucleoside transporters), member 1]} and ENT2 (SLC29A2), suggest that protein kinase CK2-mediated phosphorylation may be involved in the regulation of es- and ei-mediated nucleoside transport. We used human osteosarcoma cells transfected with catalytically active or inactive alpha' and alpha subunits of CK2 to assess the effects of CK2 manipulation on nucleoside transport activity. Expression of inactive CK2alpha' (decreased CK2alpha' activity) increased the number of binding sites (approximately 1.5-fold) for the es-specific probe [3H]NBMPR ([3H]nitrobenzylthioinosine), and increased (approximately 1.8-fold) the V(max) for 2-chloro[3H]adenosine of the NBMPR-sensitive (es) nucleoside transporter. There was a concomitant decrease in the V(max) of the NBMPR-resistant (ei-mediated) uptake of 2-chloro[3H]adenosine. This inhibition of CK2alpha' activity had no effect, however, on either the K(D) of [3H]NBMPR binding or the K(m) of 2-chloro[3H]adenosine uptake. Quantitative PCR showed a transient decrease in the expression of both hENT1 (human ENT1) and hENT2 mRNAs within 4-12 h of induction of the inactive CK2alpha' subunit, but both transcripts had returned to control levels by 24 h. These data suggest that inhibition of CK2alpha' reduced ei activity by attenuation of hENT2 transcription, while the increase in es/hENT1 activity was mediated by post-translational action of CK2. The observed modification in es activity was probably due to a CK2alpha'-mediated change in the phosphorylation state of the ENT1 protein, or an interacting protein, effecting an increase in the plasma membrane lifetime of the transport proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15500446      PMCID: PMC1134792          DOI: 10.1042/BJ20041571

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

Review 1.  Subcellular localization of protein kinase CK2. A key to its function?

Authors:  M Faust; M Montenarh
Journal:  Cell Tissue Res       Date:  2000-09       Impact factor: 5.249

2.  Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners.

Authors:  D W Litchfield; D G Bosc; D A Canton; R B Saulnier; G Vilk; C Zhang
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

3.  Further characterization of an adenosine transport system in the mitochondrial fraction of rat testis.

Authors:  A Jiménez; D Pubill; M Pallàs; A Camins; S Lladó; J Camarasa; E Escubedo
Journal:  Eur J Pharmacol       Date:  2000-06-09       Impact factor: 4.432

4.  Differential expression of human nucleoside transporters in normal and tumor tissue.

Authors:  M Pennycooke; N Chaudary; I Shuralyova; Y Zhang; I R Coe
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

Review 5.  The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms.

Authors:  R J Hyde; C E Cass; J D Young; S A Baldwin
Journal:  Mol Membr Biol       Date:  2001 Jan-Mar       Impact factor: 2.857

6.  Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.

Authors:  J L Ward; A Sherali; Z P Mo; C M Tse
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 7.  Significance of protein kinase CK2 nuclear signaling in neoplasia.

Authors:  K Ahmed; A T Davis; H Wang; R A Faust; S Yu; S Tawfic
Journal:  J Cell Biochem Suppl       Date:  2000

8.  Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.

Authors:  A Kiss; K Farah; J Kim; R J Garriock; T A Drysdale; J R Hammond
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

9.  Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site.

Authors:  M Handa; D S Choi; R M Caldeiro; R O Messing; A S Gordon; I Diamond
Journal:  Gene       Date:  2001-01-10       Impact factor: 3.688

Review 10.  The concentrative nucleoside transporter family, SLC28.

Authors:  Jennifer H Gray; Ryan P Owen; Kathleen M Giacomini
Journal:  Pflugers Arch       Date:  2003-07-11       Impact factor: 3.657

View more
  6 in total

1.  In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models.

Authors:  James Russell; Nagavarakishore Pillarsetty; Robin M Kramer; Paul B Romesser; Pooja Desai; Adriana Haimovitz-Friedman; Maeve A Lowery; John L Humm
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

2.  SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62.

Authors:  W Wang; P Liao; M Shen; T Chen; Y Chen; Y Li; X Lin; X Ge; P Wang
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

3.  Gly-46 and His-50 of yeast maltose transporter Mal21p are essential for its resistance against glucose-induced degradation.

Authors:  Haruyo Hatanaka; Fumihiko Omura; Yukiko Kodama; Toshihiko Ashikari
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

4.  The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters.

Authors:  Jaya Aseervatham; Lucky Tran; Khaled Machaca; Olga Boudker
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

5.  Bidirectional transport of 2-chloroadenosine by equilibrative nucleoside transporter 4 (hENT4): Evidence for allosteric kinetics at acidic pH.

Authors:  David Tandio; Gonzalo Vilas; James R Hammond
Journal:  Sci Rep       Date:  2019-09-19       Impact factor: 4.379

6.  Control of basal extracellular adenosine concentration in rat cerebellum.

Authors:  Mark J Wall; Alison Atterbury; Nicholas Dale
Journal:  J Physiol       Date:  2007-04-19       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.